Noble Capital Markets Initiates Research Coverage on The Beachbody Company (BODI)
Noble’s Equity Research Analyst Michael Kupinski launched coverage today with his report titled “Strong Brands To Flex Toward Growth”. The full report can be viewed, at no cost, on Channelchek.com
Noble Capital Markets Initiates Research Coverage on Twin Hospitality (TWNP)
Noble's Equity Research Analyst Joe Gomes launched coverage today with his report titled "A High-Growth, Asset Light Restaurant Franchisor". The full report can be viewed, at no cost, on Channelchek.com
Noble Capital Markets Initiates Research Coverage on Newsmax (NMAX)
Noble's Equity Research Analyst Michael Kupinski launched coverage on Newsmax today with his report titled "Riding the Red Wave"
Noble Capital Markets Initiates Research Coverage on Greenwich LifeSciences Inc. (GLSI)
Noble’s Equity Research Analyst Robert LeBoyer launched coverage today with his report titled “Initiating Coverage With An Outperform Rating and $45 Price Target” The full report can be viewed, at no cost, on Channelchek.com.
Noble Capital Markets Served As Sole Placement Agent To Ocugen (OCGN) In $20mm Direct Offering
Noble Capital Markets is pleased to announce its role as Sole Placement Agent in the completion of Ocugen's recent direct offering of $20,000,000 of its common stock at a price of $1.00 per share. The transaction priced on August 8, 2025.
Noble Capital Markets Initiates Equity Research Coverage on The Oncology Institute, Inc. (TOI)
Noble's Equity Research Analyst Robert LeBoyer launched coverage on The Oncology Institute, Inc. today with his report titled "Improving Oncology Treatment While Cutting Costs"
Noble Capital Markets Served as Co-Manager to Kratos Defense & Security Solution (KTOS) in $575mm Follow-on Offering
Noble Capital Markets is pleased to announce its role as Co-Manager in the completion of Kratos Defense & Security Solutions, Inc.’s recent underwritten follow-on offering of $575,000,000 of its common stock at a price of $38.50 per share. The transaction priced on June 25, 2025.
The Strategic Imperative: Why European HCLS Should Look To The U.S. Now
In a global economy reshaped by innovation and evolving policy, European HCLS companies have a unique opportunity to accelerate growth by investing in the U.S. middle market. Our new thought leadership series—developed by CNM LLP, Cozen O’Connor, NOBLE Capital Markets, and Pathfinder Advisors LLC—dives into the strategic, operational, and financial reasons why the time to act is now.